[vc_row css=”.vc_custom_1643731303448{margin-bottom: 40px !important;padding-top: 40px !important;padding-right: 40px !important;padding-bottom: 40px !important;padding-left: 40px !important;background-color: #edf4fa !important;}” el_class=”container”][vc_column][vc_single_image image=”175″ img_size=”full” alignment=”center”][/vc_column][/vc_row][vc_row css=”.vc_custom_1643731309917{margin-bottom: 80px !important;}” el_class=”container”][vc_column][vc_column_text]Immusmol develops mouse monoclonal antibodies (mAbs) for small molecule detection (amino acid metabolites, lipids, saccharids, toxins, steroids, etc.) by IHC or ELISA. Highly reliable, small molecule mAbs are particularly suited to diagnostic & theranostic applications.

 [/vc_column_text][/vc_column][/vc_row][vc_row css=”.vc_custom_1643731314289{margin-bottom: 40px !important;}” el_class=”container”][vc_column width=”1/2″][vc_column_text]

Advantages of small molecule monoclonal antibodies

[/vc_column_text][vc_separator color=”custom” accent_color=”#5092d0″][vc_column_text el_class=”arrow-list”]

• High specificity & affinity – Internal selection protocols are implemented to ensure our mAbs translate into robust and accurate immunoassays.
• Cross-species reactivity – Unlike proteins, small molecules are conserved throughout phylogenesis. A single small molecule mAb can thus be applied to virtually any biological sample.
• High reproducibility & availability – Produced in vitro by a single immortalized cell clone, our monoclonal antibodies meet industrial standards for quality and scalability.

[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]

Our approach for the development of small molecule mAbs

[/vc_column_text][vc_separator color=”custom” accent_color=”#5092d0″][vc_column_text el_class=”arrow-list”]

• A personalized strategy for antigen design, based on an in-depth analysis of the physico-chemical properties, immunogenicity and potential competitors of the small molecule target to address, tailored to your intended use of the antibody.
• Quality controls, deliverables, Go/No-Go decision points at the end of each phase, to ensure transparent projects with limited risk and deferred costs.
• Full ownership of the antibody-producing clone is granted to the client at the end of the study, together with at least 2mg of purified monoclonal immunoglobulin.

[/vc_column_text][/vc_column][/vc_row][vc_row el_class=”container”][vc_column][vc_column_text]

Additional options & services

[/vc_column_text][vc_separator color=”custom” accent_color=”#5092d0″][vc_column_text]To meet your specific needs, we can complement our standard mAb production process with additional services, such as:[/vc_column_text][/vc_column][/vc_row][vc_row css=”.vc_custom_1643731322510{margin-bottom: 80px !important;}” el_class=”container”][vc_column width=”1/3″][vc_column_text el_class=”arrow-list”]

• Custom molecule synthesis
• Antigen coupling validation by NMR

[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text el_class=”arrow-list”]

• Measurement of antibody binding affinity by surface plasmon resonance (Biacore)
• Complementary antibody production and purification

[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text el_class=”arrow-list”]

• Antibody validation for IHC, IF, ICC, ELISA, …
• …

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”For any specific request, plese contact us” color=”sky” align=”center” link=”url:https%3A%2F%2Fwww.immusmol.com%2Fcontact-us%2F|target:_blank”][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”40px”][/vc_column][/vc_row]